Clinical Trial 22325

• Overview

  Study Title:

  A Phase 1 Study of Irreversible Electroporation and Pembrolizumab Immunotherapy in Locally Advanced Pancreatic Cancer

• Treatments

  Therapies:

  Immunotherapy

  Medications:

  Pembrolizumab (Keytruda)

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.